Crispr Therapeutics shares owned by Oppenheimer & Co
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Oppenheimer & Co
from 13F filings
Historical chart of Oppenheimer & Co investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Oppenheimer & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.6M | 34k | 46.98 |
| 2024-03-31 | $2.0M | 30k | 68.16 |
| 2023-09-30 | $999k | 22k | 45.39 |
| 2023-06-30 | $1.1M | 19k | 56.14 |
| 2023-03-31 | $812k | 18k | 45.23 |
| 2022-12-31 | $762k | 19k | 40.65 |
| 2022-09-30 | $1.3M | 20k | 65.33 |
| 2022-06-30 | $1.1M | 18k | 60.81 |
| 2022-03-31 | $1.1M | 17k | 62.79 |
| 2021-12-31 | $1.5M | 19k | 75.81 |
| 2021-09-30 | $2.3M | 21k | 111.94 |
| 2021-06-30 | $2.8M | 17k | 161.88 |
| 2021-03-31 | $1.3M | 11k | 121.87 |
| 2020-12-31 | $1.4M | 9.1k | 153.06 |
| 2020-09-30 | $782k | 9.4k | 83.63 |
| 2020-06-30 | $734k | 10k | 73.47 |
| 2020-03-31 | $460k | 11k | 42.44 |
| 2019-12-31 | $244k | 4.0k | 61.02 |
| 2019-03-31 | $259k | 7.3k | 35.70 |
| 2018-09-30 | $275k | 6.2k | 44.34 |